![]() |
Volumn 59, Issue 11, 2000, Pages 914-917
|
Ciprofloxacin v placebo for treatment of Yersinia enterocolitica triggered reactive arthritis
b
Bayer BV
(Netherlands)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
BACTERIAL ANTIGEN;
CIPROFLOXACIN;
IMMUNOGLOBULIN A ANTIBODY;
IMMUNOGLOBULIN G ANTIBODY;
PLACEBO;
ADULT;
ANTIBIOTIC THERAPY;
ANTIGEN DETECTION;
ARTICLE;
BACTERIAL ARTHRITIS;
BACTERIAL INFECTION;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COLON BIOPSY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
HUMAN;
HUMAN TISSUE;
NONHUMAN;
PRIORITY JOURNAL;
REACTIVE ARTHRITIS;
SERODIAGNOSIS;
YERSINIA ENTEROCOLITICA;
ADOLESCENT;
ADULT;
AGED;
ANIMALS;
ANTI-INFECTIVE AGENTS;
ARTHRITIS, REACTIVE;
BLOOD SEDIMENTATION;
C-REACTIVE PROTEIN;
CIPROFLOXACIN;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
PAIN MEASUREMENT;
RATS;
RATS, INBRED BN;
RATS, INBRED LEW;
TREATMENT OUTCOME;
YERSINIA ENTEROCOLITICA;
YERSINIA INFECTIONS;
|
EID: 0033767741
PISSN: 00034967
EISSN: None
Source Type: Journal
DOI: 10.1136/ard.59.11.914 Document Type: Article |
Times cited : (39)
|
References (13)
|